PMGC Holdings Inc.
Support and Resistance Levels
Past performance
News About ELAB
All events for ELAB
All deals for ELAB
Financial Ratios
Financial Statements
ELAB vs Sector & Peers
About PMGC Holdings Inc.
PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering engineered probiotic designed to tackle the critical challenge of maintaining muscle mass during weight reduction regimens, especially those utilizing GLP-1 receptor agonists. Beyond its core operations, the company also engages in medical scientific research and development and manages various investment firms. Formerly known as Elevai Labs, Inc., the organization adopted its current name, PMGC Holdings Inc., in December 2024. Established in 2020, PMGC Holdings Inc. maintains its headquarters in Newport Beach, California. Website pmgcholdings.com
Headquarters Newport Beach, CA, US